Testing effectiveness (Phase 2)UnknownNCT01281800What this trial is testingCisplatin With Alimta or Gemcitabine in Long Infusion for MesotheliomaWho this might be right forMesothelioma Institute of Oncology Ljubljana 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT06790706What this trial is testingIMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE CancersWho this might be right forPeritoneal MesotheliomaGestational Trophoblastic TumorAnaplastic Thyroid Carcinomas+3 more Hospices Civils de Lyon 27
Testing effectiveness (Phase 2)Study completedNCT01486368What this trial is testingA Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma NCIC Clinical Trials Group 17
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Looking for participantsNCT06875076What this trial is testingMulticenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural MesotheliomaWho this might be right forPretreated Pleural Mesothelioma The First Hospital of Jilin University 25
Testing effectiveness (Phase 2)Looking for participantsNCT05960773What this trial is testingDecitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage MesotheliomaWho this might be right forMesotheliomaMalignant Mesothelioma (MM)Early-stage Mesothelioma+3 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Looking for participantsNCT06057935What this trial is testingAdditional Chemotherapy After Surgery for People With Malignant Peritoneal MesotheliomaWho this might be right forMalignant Peritoneal MesotheliomaPeritoneal MesotheliomaMesothelioma+2 more Memorial Sloan Kettering Cancer Center 64
Testing effectiveness (Phase 2)Study completedNCT00027703What this trial is testingCombination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant MesotheliomaWho this might be right forAdvanced Malignant MesotheliomaEpithelial MesotheliomaLocalized Malignant Mesothelioma+2 more National Cancer Institute (NCI) 106
Testing effectiveness (Phase 2)Study completedNCT00484276What this trial is testingStudy of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma AGC Biologics S.p.A. 57
Testing effectiveness (Phase 2)Study completedNCT02347917What this trial is testingBBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural MesotheliomaNon-Small Cell Lung Cancer Sumitomo Pharma Co., Ltd. 28
Testing effectiveness (Phase 2)Ended earlyNCT00027508What this trial is testingEcteinascidin 743 in Treating Patients With Malignant MesotheliomaWho this might be right forMalignant Mesothelioma PharmaMar
Testing effectiveness (Phase 2)Ended earlyNCT01624090What this trial is testingMithramycin for Lung, Esophagus, and Other Chest CancersWho this might be right forLung CancerEsophageal CancerMesothelioma+2 more National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Study completedNCT00017186What this trial is testingGemcitabine and Epirubicin in Treating Patients With Malignant MesotheliomaWho this might be right forMalignant Mesothelioma Alliance for Clinical Trials in Oncology 69
Large-scale testing (Phase 3)Study completedNCT00821860What this trial is testingVideo-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant MesotheliomaWho this might be right forMalignant MesotheliomaMetastatic Cancer Papworth Hospital NHS Foundation Trust 196
Testing effectiveness (Phase 2)WithdrawnNCT06654050What this trial is testingAlrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage MesotheliomaWho this might be right forMesotheliomaMalignant Mesothelioma (MM)Early-stage Mesothelioma+3 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00458913What this trial is testingBortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant MesotheliomaWho this might be right forMalignant Mesothelioma European Organisation for Research and Treatment of Cancer - EORTC 82
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)UnknownNCT01279967What this trial is testingA Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma Barts & The London NHS Trust 70
Testing effectiveness (Phase 2)Study completedNCT02568449What this trial is testingNintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is RecurrentWho this might be right forRecurrent Pleural Malignant MesotheliomaStage IV Pleural Mesothelioma Barbara Ann Karmanos Cancer Institute 20
Testing effectiveness (Phase 2)WithdrawnNCT01105390What this trial is testingAMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaWho this might be right forAdvanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more National Cancer Institute (NCI)